Where is Sonablate HIFU available now?
The Sonablate 500 is not approved for use in the U.S. It is investigational in this country and being studied for the treatment of prostate cancer in clinical trials in the U.S. The FDA has made no decision as to the safety or efficacy of the Sonablate 500 for the treatment of prostate cancer. The device is currently available for the treatment of prostate cancer in Europe, Canada, part of Asia, South America, India and the Carribean. Currently there are nearly 100 Sonablate HIFU centers worldwide on seven continents. There are over 150 physicians using the Sonablate 500 worldwide and more than 7,000 Sonablate procedures have been completed.